An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival
Korse, C. M., Taal, B. G., Bonfrer, J. M. G., Vincent, A., van Velthuysen, M. L., Baas, P.Volume:
22
Year:
2011
Language:
english
Pages:
6
DOI:
10.1093/annonc/mdr007
File:
PDF, 151 KB
english, 2011